KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Inventory (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Inventory data on record, last reported at $2.3 billion in Q4 2025.

  • For Q4 2025, Inventory rose 2.29% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $2.3 billion, up 2.29%, while the annual FY2025 figure was $2.3 billion, 2.29% up from the prior year.
  • Inventory reached $2.3 billion in Q4 2025 per ZBH's latest filing, down from $2.5 billion in the prior quarter.
  • Across five years, Inventory topped out at $2.5 billion in Q2 2021 and bottomed at $2.1 billion in Q2 2022.
  • Average Inventory over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2023.
  • Peak YoY movement for Inventory: dropped 16.2% in 2022, then grew 11.08% in 2023.
  • A 5-year view of Inventory shows it stood at $2.1 billion in 2021, then dropped by 0.04% to $2.1 billion in 2022, then rose by 11.08% to $2.4 billion in 2023, then decreased by 6.28% to $2.2 billion in 2024, then rose by 2.29% to $2.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $2.3 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.5 billion in Q2 2025.